Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
isopropyl alcohol + povidone-iodine + lidocaine hydrochloride + methylprednisolone
- Development stage
- Unknown
- Lead developer
- Asclemed USA
- Modality
- Small Molecules
- Administration
- Topical, Intralesional, Intraarticular, Intramuscular, Parenteral
01
Overview
This entry most plausibly refers to a **multi-ingredient topical or locally administered compounded combination** containing isopropyl alcohol and povidone-iodine as antiseptic/disinfectant components, lidocaine hydrochloride as a local anesthetic, and methylprednisolone as an anti-inflammatory corticosteroid. The provided source text, however, specifically documents indications for **methylprednisolone acetate injectable suspension** rather than for this exact four-ingredient combination product. Accordingly, the exact branded product identity, sponsor, formulation details, and regulatory status of the combination are not established from the supplied evidence, and the combination should be treated as a nonstandard formulation rather than a clearly verified marketed drug asset.
- Other names
- isopropyl alcohol + povidone-iodine + lidocaine hydrochloride + methylprednisolone
02
Targets
GR (Glucocorticoid receptor)NaV (Voltage-gated sodium channels)MR (Mineralocorticoid receptor)
Beyond the preview
Go deeper on isopropyl alcohol + povidone-iodine + lidocaine hydrochloride + methylprednisolone.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on isopropyl alcohol + povidone-iodine + lidocaine hydrochloride + methylprednisolone.